Decheng Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals

  • Investments
  • 97

  • Portfolio
  • 29

  • Exits
  • 40

Exits

Decheng Capital General Information

Company Description

Founded in 2012, Decheng Capital is a venture capital firm based in Menlo Park, California. The firm seeks to invest in early-stage life science companies and growth stage healthcare companies. This firm is a Registered Investment Adviser (RIA).

Business Details

Website
www.decheng.com
Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • 3000 Sand Hill Road
  • Building 2, Suite 110
  • Menlo Park, CA 94025
  • United States
+1 (650)

Decheng Capital Investments (97)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ottimo Pharma 12-Dec-2024 Later Stage VC Drug Discovery Startup
Aclaris Therapeutics 18-Nov-2024 Drug Discovery Generating Revenue
Nalu Medical 09-Oct-2024 Therapeutic Devices Generating Revenue
Adela 27-Jul-2024 Diagnostic Equipment Generating Revenue
Aardvark Therapeutics 09-May-2024 Drug Discovery Generating Revenue/Not Profitable
Upstream Bio 05-Apr-2024 Drug Discovery Generating Revenue/Not Profitable
ImmPACT Bio 01-Apr-2024 Drug Discovery Generating Revenue
FireFly Bio 15-Feb-2024 Drug Discovery Generating Revenue
ConjugateBio 01-Dec-2023 Early Stage VC Biotechnology Stealth
YolTech Therapeutics 21-Sep-2023 Early Stage VC Drug Discovery Generating Revenue
You’re viewing 10 of 97 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Decheng Capital Exits (40)

Company Name Exit Date Exit Type Exit Size
ImmPACT Bio 31-Oct-2024 Merger/Acquisition
Upstream Bio 11-Oct-2024
AnHeart Therapeutics 09-Apr-2024
Xtremity 28-Mar-2024
CG Oncology 25-Jan-2024
Alpine Immune Sciences 06-Nov-2023
Mindstrong 03-Jun-2023
Acelyrin 05-May-2023
Apexigen 01-Aug-2022 Reverse Merger
GenapSys 14-Jul-2022 Bankruptcy: Admin/Reorg
You’re viewing 10 of 40 exits. Get the full list »

Decheng Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Decheng Capital‘s full profile, request access.

Request a free trial

Decheng Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Decheng Capital Co-Investors (159)

Name With Exits Lead Partner Series Industry
OrbiMed 6 Series chart Industry bar
Foresite Capital Series chart Industry bar
Surveyor Capital Series chart Industry bar
HBM Healthcare Investments Series chart Industry bar
RTW Investments Series chart Industry bar
You’re viewing 5 of 159 co-investors. Get the full list »

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Decheng Capital China Management Shanghai, China 2012

Decheng Capital FAQs

  • What is Decheng Capital?

    Founded in 2012, Decheng Capital is a venture capital firm based in Menlo Park, California.

  • When was Decheng Capital founded?

    Decheng Capital was founded in 2012.

  • Where is Decheng Capital headquartered?

    Decheng Capital is headquartered in Menlo Park, CA.

  • What is Decheng Capital's total asset value?

    Decheng Capital has around in total assets under management.

  • How many investments has Decheng Capital made?

    Decheng Capital has made 97 investments.

  • What has Decheng Capital invested in?

    Decheng Capital has made numerous investments in companies like Ottimo Pharma, Aclaris Therapeutics, and Nalu Medical within the Drug Discovery and Therapeutic Devices industries.

  • What has Decheng Capital invested in recently?

    Decheng Capital's latest investment was on 12-Dec-2024 in Ottimo Pharma, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »